Project Grant R01HL178752
- The Project Grant award of $692,846.00 from the National Heart Lung and Blood Institute's Cardiovascular Diseases Research program (CFDA 93.837) will fund the "Better Heart Study" at the University of Pennsylvania. The study aims to utilize behavioral science strategies to increase hypertension diagnosis and treatment in India, where hypertension prevalence remains high and many individuals are undiagnosed or not receiving care. The project will test two scalable behavioral...
- The National Heart Lung and Blood Institute awarded a $145,419 Project Grant titled "Implementation Determinants and Community-Based Prevention for Cardiometabolic Disease in Mozambique: A Pilot Study" under the Cardiovascular Diseases Research program (CFDA 93.837). This award supports formative research to characterize determinants for effective implementation of integrated care for type 2 diabetes, hypertension, and HIV within ongoing health systems strengthening efforts in public...
- This federal Project Grant award of $130,065 was provided by the National Heart Lung and Blood Institute under the Cardiovascular Diseases Research federal grant program (CFDA 93.837) to conduct systematic economic analyses on the costs associated with implementing a chronic care model for patients with hypertension. The grant supports a study led by principal investigator Dr. Elaine Khoong and collaborators Dr. Dhruv Kazi, Dr. Lina Tieu, and Dr. Lisa Ochoa-Frongia. The project aims to...
- This federal Project Grant award of $708,678, provided by the National Heart, Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research), aims to conduct a Sequential Multiple Assignment Randomized Trial (SMART) to reduce food insecurity and improve adherence in patients with hypertension. The key products and services to be delivered under this grant include: Determining the most effective initial food insecurity intervention (resource information or community health worker...
- This $631,589 Project Grant award from the National Heart Lung and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837) will examine the implementation, effectiveness, and cost-effectiveness of two strategies for integrating a community health worker-facilitated hypertension telehealth intervention into primary health centers in Kenya. The goal is to address multi-level barriers to effective hypertension treatment and management. The two implementation approaches are:...
- This federal Project Grant award, valued at $162,703.00 and granted by the National Heart Lung and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research), aims to determine whether streamlined, standardized blood pressure (BP) measurement protocols can be implemented in primary care settings. The project builds on the Alabama Cardiovascular Cooperative's Heart Health Improvement Project and seeks to improve the accuracy and efficiency of BP measurements to inform treatment decisions...
- This $285,195 project grant was awarded on August 20, 2025 by the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) to Brigham & Women's Hospital Inc. to support research on improving hypertension management through patient self-titration of antihypertensive medications. The project aims to adapt this intervention to the U.S. primary care context by assessing patient preferences, provider perspectives, and integration with electronic health records and...
- This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to evaluate the implementation of a heart failure polypill strategy in India. The award, valued at $498,129.23 and starting on December 9, 2024, supports a multi-center randomized clinical trial to assess whether a polypill containing guideline-directed medications can reduce cardiovascular mortality and heart failure hospitalizations compared to usual care in adults...
- The George Washington University received a $178,367 Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) for the "SUPPORT YOUR HEART: FEASIBILITY TRIAL OF A CARDIOVASCULAR HEALTH INTERVENTION FOR YOUNG ADULTS" project. This 2-year feasibility study aims to develop and evaluate a telephone-delivered health coaching intervention for young adults targeting the American Heart Association's "Life's Essential 8"...
- The University of Arizona was awarded a $735,838 project grant by the National Heart, Lung, and Blood Institute (CFDA 93.837 - Cardiovascular Diseases Research) on July 15, 2025. The grant supports research into the role of hexokinase 1 (HK1) mitochondrial dislocation in the development of heart failure with preserved ejection fraction (HFpEF). The key objectives are to investigate how HK1 dislocation leads to increased protein O-GlcNAcylation in cardiac endothelial cells, and to assess...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $334,950 to evaluate the implementation of the World Health Organization's HEARTS technical package for improving hypertension and diabetes care in primary care facilities in Guatemala. The 5-year project, starting on September 25, 2025, will conduct a mixed-methods evaluation over a 30-month implementation period followed by a 30-month maintenance period. Key objectives include assessing the reach, effectiveness, adoption, implementation, and maintenance of the HEARTS model in the Guatemalan Ministry of Health primary care system. The award recipient is the Regents of the University of Michigan, a prominent U.S. research institution, which will leverage its expertise in medical research, implementation science, and global health to support this critical public health initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $335.0k | 9/22/25 |